Detalhe da pesquisa
1.
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
Blood
; 140(25): 2697-2708, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700381
2.
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
Blood
; 140(19): 2024-2036, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914220
3.
Cost-effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola-R-CHP) in previously untreated diffuse large B-cell lymphoma in Germany.
Br J Haematol
; 202(4): 771-775, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188351
4.
Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer.
Adv Exp Med Biol
; 1243: 147-162, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297217
5.
Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Cancer
; 125(18): 3234-3241, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154669
6.
Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock.
Am Heart J
; 199: 181-191, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754660
7.
Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis.
Pancreatology
; 16(6): 966-972, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727097
8.
Shared Decision-Making and Patient Empowerment in Preventive Cardiology.
Curr Cardiol Rep
; 18(5): 49, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27098670
9.
Painting blood vessels and atherosclerotic plaques with an adhesive drug depot.
Proc Natl Acad Sci U S A
; 109(52): 21444-9, 2012 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23236189
10.
Characterization of a fluorescent probe for imaging nitric oxide.
J Vasc Res
; 51(1): 68-79, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335468
11.
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714474
12.
Management of aggressive lymphoma after CAR T-cell therapy failure.
Hematology Am Soc Hematol Educ Program
; 2023(1): 364-369, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066908
13.
Thinking "outside the germinal center": Re-educating T cells to combat follicular lymphoma.
Blood Rev
; 61: 101099, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173225
14.
How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations.
JACC CardioOncol
; 5(3): 281-291, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37397077
15.
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.
Cancers (Basel)
; 15(6)2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980632
16.
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Leukemia
; 37(6): 1324-1335, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031300
17.
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Blood Cancer J
; 13(1): 9, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631449
18.
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
JAMA Oncol
; 9(10): 1423-1431, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615958
19.
Circulating Tumor DNA in Lymphoma.
Curr Hematol Malig Rep
; 17(6): 298-305, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214943
20.
Incorporating novel agents into frontline treatment of Hodgkin lymphoma.
Hematology Am Soc Hematol Educ Program
; 2022(1): 706-716, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485085